On March 29, the U.S. Food and Drug Administration (FDA) approved Omontys (peginesatide) to treat anemia in adult patients who had chronic kidney disease and are on dialysis. Read more.
Δ
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
Notifications
